Abstract:Background and objective: Hematopoietic stem cells are being increasingly used for treatment of malignant and nonmalignant disorders. Various attempts have been made in recent years to expand and manipulate these cells in order to increase their therapeutic potential. A Working Group on Hematopoietic Cells has analyzed the most recent advances in this field. Evidence and information sources: The method used for preparing this review was an informal consensus development. Members of the Working Group met three times, and the participants at these meetings examined a list of problems previously prepared by the chairman. They discussed the single points in order to achieve an agreement on different judgments, and eventually approved the final manuscript. Some authors of the present review have been working in the field of stem cell biology, processing and transplantation, and have contributed original papers in peer-reviewed Journals. In addition, the material examined in the present review includes articles and abstracts published in Journals covered by the Science Citation Index and Medline. State of art: Over the last decade, recombinant DNA technology has allowed the large scale production of cytokines controlling the proliferation and differentiation of hemo-lymphopoietic cells. Thus, in principle, ex vivo manipulation of hemopoiesis has become feasible. The present review covers three major area of interest in experimental and clinical hematology: manipulation of hematopoietic stem/progenitor cells, cytotoxic effector cells and antigen presenting dendritic cells. Preliminary data demonstrate the possibility of using, in a clinical setting, ex vivo expanded hematopoietic cells with the aim of reducting, and perhaps abrogating, the myelosuppression after high-dose chemotherapy. Concurrently, other important potential applications for ex vivo manipulation of hematopoietic cells have recently been investigated such as the generation and expansion of cytotoxic cells for cancer immunotherapy, and the large scale production of professional antigen presenting cells capable of initiating the process of immune response. Conclusions and perspectives: Present and future challenges in this field are represented by the expansion of true human stem cells without maturation, to extend this strategy to allogeneic stem cell transplantation as well as the manipulation of cycling of primitive progenitors for gene therapy programs. The selective outgrowth of normal progenitor cells over neoplastic cells to achieve tumor-free autografts may ameliorate the results of autologous transplantation. The selective production of cellular subsets to manipulate the graft versus-host and graft versus-tumor effects and anti-tumor vaccination strategies may be important to improve cellular adoptive immunotherapy.

Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies

Stem Cells Collection and Mobilization in Adult Autologous/Allogeneic Transplantation: Critical Points and Future Challenges

Advances in cell therapy: progress and challenges in hematological and solid tumors

Ex vivo expansion of hematopoietic cells and their clinical use

Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned

Advances in ex vivo expansion of hematopoietic stem and progenitor cells for clinical applications

Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders

Specific Blood Cells Derived From Pluripotent Stem Cells: An Emerging Field With Great Potential In Clinical Cell Therapy

Optimizing Blood Stem Cell Transplants Through Cellular Engineering

Cell Therapy: Past, Present, and Future

Advancements and challenges in stem cell transplantation for regenerative medicine

Past, Present, and Future Efforts to Enhance the Efficacy of Cord Blood Hematopoietic Cell Transplantation

Advancements in Hematopoietic Stem Cell Gene Therapy: A Journey of Progress for Viral Transduction

Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation

Hematopoietic Cells from Pluripotent Stem Cells: Hope and Promise for the Treatment of Inherited Blood Disorders

Cell Therapy as a Way to Increase the Effectiveness of Hematopoietic Stem Cell Transplantation

Hematopoietic stem cell collection for sickle cell disease gene therapy

Cellular Immunotherapy for Hematological Malignancy: Recent Progress and Future Perspectives.

The quest for the holy grail: overcoming challenges in expanding human hematopoietic stem cells for clinical use

Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation

Immune modulation in transplant medicine: a comprehensive review of cell therapy applications and future directions